Clinical Trial

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-04.
Status change: Not Yet Recruiting → Recruiting 2025-12-01
Trial Details
NCT Number NCT07007156
Lead Sponsor Consorci Sanitari de l'Alt Penedès i Garraf
Conditions Acute Disease
Enrollment 199 participants
Start Date 2025-06-12
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-05